GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release.
Gupta RA, Higham JP, Pearce A, Urriola-Muñoz P, Barker KH, Paine L, Ghooraroo J, Raine T, Hockley JRF, Rahman T, St John Smith E, Brown AJH, Ladds G, Suzuki R, Bulmer DC.
Gupta RA, et al.
Pain. 2024 Oct 3. doi: 10.1097/j.pain.0000000000003399. Online ahead of print.
Pain. 2024.
PMID: 39382322